A ccidental hypothermia (i.e., an involuntary drop in core body temperature to <35°C [95°F]) is a condition associated with significant morbidity and mortality. 1-4 Each year, approximately 1500 patients in the United States have hypothermia noted on their death certificate; however, the incidence of primary and secondary hypothermia and the associated morbidity and mortality remain unknown. 5 In a single tertiary care center, 14 different rewarming methods were used to treat 84 cases of accidental hypothermia, 3 which reflects the uncertainties about treatment and the potential for complications. 3 Certain treatment approaches are available only in specialized centers, and clarification is needed regarding the choice between transporting a patient to a specialized center and providing treatment locally. Existing recommendations do not include recent developments in rewarming methods nor do they assist with decisions regarding transportation. 6-8
With cold exposure, the initial response of the body is to maintain a normal core temperature (approximately 37°C [99°F]) by means of active movement and involuntary shivering. Primary hypothermia occurs when heat production in an otherwise healthy person is overcome by the stress of excessive cold, especially when the energy stores of the body are depleted. Secondary hypothermia can occur in ill persons with a wide variety of medical conditions (Table 1) , even in a warm environment. Death in patients with secondary hypothermia is often caused by the underlying condition rather than by hypothermia. In all types of hypothermia, consciousness, breathing, and circulation are initially intact but are impaired as the body cools. 10 Some patients with a core temperature of less than 28°C (82°F) engage in paradoxical undressing. 11 Atrial fibrillation is common when the core temperature is less than 32°C (90°F) and is not worrisome in the absence of other signs of cardiac instability. 9 The risk of cardiac arrest increases as the core temperature drops below 32°C, and increases substantially if the temperature is less than 28°C. 12 
DI AGNOSIS
Patients should be considered to have hypothermia if they have a history of cold exposure or a disease that predisposes them to hypothermia and if they have a cold trunk or a core temperature of less than 35°C (95°F) (Fig. 1) . Hypothermia can be staged clinically on the basis of vital signs with the use of the Swiss staging system of hypothermia (stages HT I to HT IV) 10 (Table 2) ; this system is favored over traditional staging (mild, moderate, severe, and profound hypothermia) 12 whenever the core temperature cannot be readily measured.
Measurement of the core temperature will confirm staging and inform transport and management decisions. Properly calibrated, low-reading thermometers are required but are not always available in the prehospital setting. The recorded temperature can vary depending on the body site, perfusion, and environmental temperature. In an intubated patient, insertion of a thermistor probe in the lower third of the esophagus is the preferred method. 9 Measurements obtained with the use of a proximally placed esophageal probe may be falsely elevated owing to ventilation with warmed gases. A thermistor probe in contact with the tympanic membrane accurately reflects brain temperature, provided that the ear canal is free of snow and cerumen and is well insulated against the environment. 14 Measurements obtained with the use of infrared cutaneous, aural, and oral thermometers are often inaccurate in patients with hypothermia. The bladder temperature may be falsely elevated during peritoneal lavage. Rectal probes should be inserted to a depth of 15 cm, but readings may lag behind core temperature during rewarming. 9 When accurate measurement of the core temperature is not feasible, as in some field settings, decisions regarding management should be based on the clinical Swiss staging system.
PR EHOSPI TA L T R E ATMEN T
Priorities for prehospital treatment include careful handling of the patient, provision of basic or advanced life support, passive and active external rewarming, and transport to an appropriate facility. Detecting a pulse in a patient with hypothermia may be difficult, so signs of life and pulse should be checked carefully for 60 seconds. Persistent breathing or movement by the patient should prompt a strategy of watchful waiting, but if no signs of life are detected, then cardiopulmonary resuscitation (CPR) should be started. 7, 8 Full-body insulation and rewarming should be provided for all patients as long as it does not impede CPR or delay transport. 7 For rewarming in the prehospital setting, only chemical, electrical, or forced-air heating packs or blankets provide a substantial amount of heat transfer (Table 3) . 25, 26 Advanced airway management 7 should be performed if indicated, since the risk of triggering a malignant arrhythmia is low. 13, 27 minished release of antidiuretic hormone) and vasodilatation during rewarming. 8 Warm crystalloid fluids should be administered on the basis of volume status and glucose, electrolyte, and pH measurements; resuscitation with a large volume of normal saline may aggravate acidosis, so alternative crystalloids should be considered. Vasopressors may be used to treat vasodilatory hypotension, but caution is required, owing to the potential for arrhythmia and the risk of peripheral-tissue perfusion, particularly in patients at risk for frostbite. 29 T R A NSP OR T Conscious, shivering patients (stage HT I) can be treated in the field if they are uninjured or transported to the closest hospital if rewarming is not possible in the field ( Fig. 1 and Table 2 ). Patients with impaired consciousness (stage HT II, HT III, or HT IV) should be assessed for cardiac instability. Patients with stable circulation require active external and minimally invasive rewarming (placement in a warm environment; application of chemical, electrical, or forced-air heating packs or blankets; and administration of warm parenteral fluids) ( Table 2 ) and should be taken to the closest hospital that can provide these measures. Patients with prehospital cardiac instability (e.g., systolic blood pressure of <90 mm Hg or ventricular arrhythmias), 9 those with a core temperature of less than 28°C (82°F), and those in cardiac arrest should be transported to a center capable of providing extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass, unless coexisting conditions (e.g., trauma) mandate transport to a closer facility.
Owing to the decrease in cerebral oxygen requirements with cooling, 8 survival without neurologic impairment may be possible even when it is necessary to perform CPR for hours. The longest reported duration of CPR with full neurologic recovery after extracorporeal rewarming is 190 minutes. 30 Survival after 390 minutes of CPR has been documented when rewarming with forcedair blankets and peritoneal lavage was used. 31 If the decision is made to stop at a facility where the serum potassium level can be measured, a hospital en route to a center that can provide ECMO or cardiopulmonary bypass should be selected. If the serum potassium level is higher than 12 mmol per liter (see discussion below), termination of CPR should be considered (Fig. 1) . When the patient transport time will be considerable, the use of a mechanical chest-compression device should be considered, since it preserves the energy of the rescue crew, increases safety, and may improve the outcome. 32 The destination hospital should be contacted in advance to ensure that ECMO or cardiopulmonary bypass is available. In remote areas, the transport adviser must balance the risk of a longer transport time against the potential benefit of treatment in a center that can provide ECMO or cardiopulmonary bypass.
R E SCUE C OL L A PSE A ND A F TER DROP
Rescue collapse is defined as cardiac arrest that is related to the extrication and transport of a patient with deep hypothermia (stage HT III). 2, 4, 21, 22, 31, 33, 34 Rescue collapse has been attributed to circulatory collapse due to hypovolemia, cardiac arrhythmias triggered by interventions (e.g., movement of the HT I, HT II, HT III, and HT IV refer to the four stages of hypothermia as defined by the Swiss staging system.
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To convert values for temperature to degrees Fahrenheit, multiply by 9/5 and add 32. Obvious signs of irreversible death include decapitation, truncal transection, decomposition of the whole body, and a chest wall that is not compressible (i.e., the whole body is frozen solid). Rigor mortis as well as fixed and dilated pupils may be present in patients with reversible hypothermia. Active external and minimally invasive rewarming techniques include placement of the patient in a warm environment; use of chemical, electrical, or forced-air heating packs or blankets; and parenteral administration of warm fluids (38 to 42°C [100 to 108°F]). A systolic blood pressure of less than 90 mm Hg is a reasonable prehospital estimate of cardiac instability, but for inhospital decisions, the minimum sufficient circulation for a patient with a core temperature of less than 28°C (82°F) has not been defined. Therefore, it is not known at what point a patient with refractory cardiac instability should be transitioned to extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass (CPB). In remote areas, the transport adviser must balance the risk of increased transport time with the potential benefit of treatment in a center that can provide ECMO or CPB. For a patient with cardiac arrest in a remote area, the need for ECMO or CPB can be confirmed by measuring the serum potassium level at an intermediate hospital, ideally en route toward a center that can provide ECMO or CPB. When transfer to such a center is not feasible, active external and alternative internal rewarming techniques should be used. DNR denotes do not resuscitate, IO intraosseous, IV intravenous, and ROSC return of spontaneous circulation. patient or central venous catheterization), and further cooling. 9, 12, 35 Afterdrop is defined as continued core cooling after rescue, which has been documented in artificial cooling experiments or inferred through discrepancies between rectal and core temperatures. With the use of active external and minimally invasive rewarming and concurrent esophageal temperature measurement, afterdrop has not been reported. 15, 16, 36 
IN-HOSPI TA L T R E ATMEN T
In a patient with hypothermia and stable circulation, active external and minimally invasive rewarming is indicated (Table 2) , 7,36 as well as treatment of any condition causing secondary hypothermia (Table 1) . Given the increased risk of complications, such as hemorrhage or thrombosis, with invasive rewarming methods (e.g., bodycavity lavage, endovascular devices, and extracorporeal heating systems), as well as the absence of evidence that these methods improve the outcome, the best approach may be the use of active external and minimally invasive rewarming. 37 When selecting the rewarming method and rate (Table 3) , clinicians should consider accessibility to an appropriate facility, local expertise, resources, and characteristics of the patient. When central venous access is required, it is important to keep the tip of the catheter (and guide wire) far from the heart in order to minimize the risk of arrhythmia. 9 ECMO or cardiopulmonary bypass should be considered for patients with hypothermia and cardiac instability who do not have a response to medical management. At a core temperature of 28°C (82°F), oxygen consumption and the pulse rate are usually decreased by 50%, 9 but the minimum sufficient circulation has not been defined; therefore, it is not known at what point a patient with cardiac instability should undergo ECMO or cardiopulmonary bypass. The use of ultrasonography and near-infrared spectroscopy to visualize blood flow and assess cerebral oxygenation may assist with these decisions in the future. 38, 39 When signs of life and vital signs are absent (stage HT IV), there is consensus that treatment with ECMO or cardiopulmonary bypass is safe and efficient. 1,2,6-8,12,22,24,33,34,40-42 Among patients treated with ECMO or cardiopulmonary bypass, the rate of survival without neurologic impairment is 47 to 63%. 1,2,33,41 For patients with hypothermia of stage HT IV who are not treated with ECMO or cardiopulmonary bypass, limited data are available, but the survival rate is likely to be less than 37%. 13, 16, 43 The advantage of ECMO or cardiopulmonary bypass relates to the establishment of blood flow during rewarming. Support with ECMO has resulted in improved outcomes, as compared with traditional cardiopulmonary bypass, 24,41 probably owing to the high incidence of severe pulmonary failure after rewarming, which can be treated more efficiently with ECMO. If ECMO or cardiopulmonary bypass is not avail- 10 CPB denotes cardiopulmonary bypass, CPR cardiopulmonary resuscitation, and ECMO extracorporeal membrane oxygenation. † Measurement of body core temperature is helpful but not mandatory. The risk of cardiac arrest increases as the core temperature drops below 32°C and increases substantially if the temperature is less than 28°C. 12, 13 To convert values for temperature to degrees Fahrenheit, multiply by 9/5 and add 32. able and transport to a facility with these capabilities is not possible, circulation should be supported with CPR while the patient is rewarmed with a locally available, alternative internal rewarming technique (Table 3) . 16, 20, 21, 31 According to case reports, thoracic lavage has restored spontaneous circulation within 2 hours 21 and is a reasonable alternative rewarming technique when ECMO or cardiopulmonary bypass is not available. 7 In patients with a return of spontaneous circulation, multiorgan failure should be expected, and respiratory support with ECMO may be required. Standard management after cardiac arrest is indicated, and some experts recommend 24 hours of therapeutic hypothermia (32 to 34°C [90 to 93°F]), but evidence in support of this approach is lacking. If a patient with cardiac arrest due to hypothermia is rewarmed to a core body temperature that is higher than 32°C and asystole persists, irreversible cardiac arrest is very likely, and termination of CPR should be considered.
MODIFIED V ER SUS S TA NDA R D A DVA NCED L IFE SUPP OR T
The use of vasopressors in animal models of hypothermic cardiac arrest have had mixed results, with a small number of studies showing a benefit. 44 The guidelines of the European Resuscitation Council recommend a modified approach to advanced life support, consisting of up to three defibrillations, with epinephrine withheld until the core temperature is higher than 30°C (86°F) and with the interval between doses doubled until the core temperature is higher than 35°C (95°F). 8 These recommendations conflict with the American Heart Association guidelines, which state, "It may be reasonable to consider administration of a vasopressor during cardiac arrest according to the standard ALS [advanced life support] algorithm concurrently with rewarming strategies." 7 Hence, the administration of up to three doses of medication and defibrillation is likely to be a reasonable approach, with further dosing guided by the clinical response. 45 
SERUM P O TA SSIUM
Increased serum potassium levels can be caused by hypoxic and traumatic cell death, medications (e.g., depolarizing neuromuscular blockers), and a variety of medical conditions. A severely elevated serum potassium level is associated with nonsurvival and is considered a marker of hypoxia before cooling. 1, 33, 46 The highest recorded levels of serum potassium in patients with accidental hypothermia who were successfully resuscitated are 11.8 mmol per liter in a 31-month-old child, 42 9.5 mmol per liter in a 13-year-old child, 47 7 We recommend that termination of CPR be considered when the potassium level is higher than 12 mmol per liter (Fig. 1 
AVALANCHE BURIAL WITHOUT VITAL SIGNS
The maximum reported cooling rate in a person who had been completely buried in an avalanche was 9°C (48°F) per hour. 17, 34 With a burial time of less than 35 minutes, life-threatening hypothermia is unlikely, owing to insufficient cooling time, and trauma and hypoxia should be suspected as the cause if vital signs are absent. 7, 8, 29, 46 If the burial time exceeds 35 minutes, the airway is packed with snow, and the patient is asystolic, hypoxia probably preceded hypothermia and CPR is unlikely to be beneficial. However, if the burial time is longer than 35 minutes and the airway is not blocked, severe hypothermia should be suspected and the patient should be treated accordingly (Fig. 1) . 
DROWNING WITHOUT VITAL SIGNS
Persons who have been submerged in cold water may have a better outcome than those submerged in warm water. 55 If the patient's history indicates immersion in cold water (i.e., the body was exposed to cold water, but the patient was able to breathe) and it is likely that the body cooled before the onset of hypoxia and cardiac arrest (stage HT IV), survival without neurologic impairment may be possible, 40, 56 and resuscitation should proceed (Fig. 1) . If the history indicates submersion in cold water (i.e., the body was exposed to cold water, and the patient was unable to breathe) before cooling, the outcome may be worse. 1, 33 The longest period of submersion that a person has survived without neurologic impairment was 66 minutes in a child who was 2.5 years old (the child's core temperature was 19°C [66°F]). 57 
OU T C OME
The lowest reported core body temperatures in patients with full neurologic recovery are slightly less than 14°C (57°F) in a case of accidental hypothermia 40 and 9°C (48°F) in a case of induced hypothermia. 58 A survey of patients with stage IV hypothermia at one center showed that organ failure was common 24 hours after admission, and among fatal cases of organ failure, the most common cause of death was pulmonary edema. 3 Patients with primary hypothermia and cardiac stability who have been treated with active external and minimally invasive rewarming have a rate of neurologically intact survival of approximately 100%, 16 whereas for patients with cardiac arrest treated with extracorporeal rewarming, the rate is approximately 50%. No potential conflict of interest relevant to this article was reported.
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